We are live on
!
Find out more
CM
Castleark Management Portfolio holdings
AUM
$3.71B
1-Year Est. Return
65.19%
This Fund
S&P 500
This Quarter
Est. Return
+12.23%
1 Year Est. Return
+65.19%
3 Year Est. Return
+247.97%
5 Year Est. Return
+412.62%
10 Year Est. Return
+3,903.2%
AUM
$3.45B
AUM Growth
-$102M
(-2.9%)
Cap. Flow
-$686M
Cap. Flow
% of AUM
-19.93%
Top 10 Holdings %
Top 10 Hldgs %
24.74%
Holding
463
New
121
Increased
97
Reduced
62
Closed
149
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TJX Companies
TJX
|
+$94.6M |
| 2 |
Parker-Hannifin
PH
|
+$89.5M |
| 3 |
Costco
COST
|
+$84M |
| 4 |
Gilead Sciences
GILD
|
+$80.3M |
| 5 |
Capri Holdings
CPRI
|
+$74.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$471M |
| 2 |
NXP Semiconductors
NXPI
|
+$100M |
| 3 |
CVS Health
CVS
|
+$83.4M |
| 4 |
Meta Platforms (Facebook)
META
|
+$83.3M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$82.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.93% |
| 2 | Industrials | 16.49% |
| 3 | Energy | 15.62% |
| 4 | Technology | 13.96% |
| 5 | Healthcare | 12.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Medtronic
MDT
$120B
| $195K | 0.01% |
3,400
+520
| +18% | +$29.5K |
|
|
CFN
302
DELISTED
CAREFUSION CORPORATION
CFN
| $185K | 0.01% |
4,650
-9,100
| -66% | -$354K |
|
|
NFX
303
DELISTED
Newfield Exploration
NFX
| $180K | 0.01% |
7,300
| – | – |
|
304
Union Pacific
UNP
$169B
| $168K | ﹤0.01% |
2,000
-879,488
| -100% | -$69.6M |
|
305
Microsoft
MSFT
$3.69T
| $150K | ﹤0.01% |
4,000
| – | – |
|
306
PepsiCo
PEP
$185B
| $133K | ﹤0.01% |
1,600
| – | – |
|
|
AGN
307
DELISTED
Allergan Inc
AGN
| $133K | ﹤0.01% |
1,200
| – | – |
|
308
Deere & Co
DE
$184B
| $128K | ﹤0.01% |
1,400
| – | – |
|
309
Cisco
CSCO
$434B
| $112K | ﹤0.01% |
5,000
| – | – |
|
|
PSXP
310
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $106K | ﹤0.01% |
2,800
| – | – |
|
311
AbbVie
ABBV
$465B
| $95K | ﹤0.01% |
1,800
| – | – |
|
312
McDonald's
MCD
$179B
| $78K | ﹤0.01% |
800
| – | – |
|
|
WBA
313
DELISTED
Walgreens Boots Alliance
WBA
| $57K | ﹤0.01% |
1,000
+520
| +108% | +$30.3K |
|
314
Stryker
SYK
$108B
| $53K | ﹤0.01% |
700
+360
| +106% | +$26.3K |
|
315
Adeia
ADEA
$2.75B
| – | – |
-786,807
| Closed | -$5.53M |
|
316
Allison Transmission
ALSN
$10.1B
| – | – |
-22,800
| Closed | -$650K |
|
317
Apogee Enterprises
APOG
$781M
| – | – |
-163,883
| Closed | -$6.52M |
|
|
AVDL
318
DELISTED
Avadel Pharmaceuticals
AVDL
| – | – |
-477,644
| Closed | -$6.83M |
|
319
BJ's Restaurants
BJRI
$1.28B
| – | – |
-172,175
| Closed | -$6.2M |
|
320
Brookdale Senior Living
BKD
$2.83B
| – | – |
-341,856
| Closed | -$11M |
|
321
Booking.com
BKNG
$129B
| – | – |
-552,000
| Closed | -$25.6M |
|
322
Bristol-Myers Squibb
BMY
$130B
| – | – |
-12,100
| Closed | -$619K |
|
323
Calix
CALX
$2.24B
| – | – |
-550,440
| Closed | -$5.27M |
|
324
Crown Holdings
CCK
$12.2B
| – | – |
-10,100
| Closed | -$450K |
|
325
CF Industries
CF
$20.5B
| – | – |
-197,250
| Closed | -$11M |
|
Similar funds
MSC
BC
FEG
HCM
OH
BCM
CCI
MCM
Castleark Management's Q4 2013 Portfolio in Review
As of Q4 2013, Castleark Management held 463 positions worth $3.45B, down 2.9% from $3.55B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Castleark Management withdrew a net $686M in Q4 2013, closing 149 positions and reducing 62 holdings. Its most notable exit was NXP Semiconductors, an estimated $100M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 14% a quarter earlier, followed by Industrials and Energy.
Against the trend, Castleark Management opened a new position in LinkedIn Corporation worth $64.8M.
- Castleark Management's largest Q4 2013 buy was LinkedIn Corporation: 298,620 shares worth $64.8M.
- Castleark Management added most to TJX Companies in Q4 2013, an estimated $94.6M increase.
- Castleark Management's biggest Q4 2013 reduction was Apple, cutting an estimated $471M.
- Castleark Management fully exited NXP Semiconductors in Q4 2013, selling an estimated $100M.
- Castleark Management's ten largest holdings make up 25% of its $3.45B portfolio in Q4 2013.
- Castleark Management opened 121 new positions and closed 149 in Q4 2013.
- Castleark Management's portfolio value fell 2.9% quarter-over-quarter to $3.45B.
Based on Castleark Management's 13F filing for Q4 2013, filed 20 Feb 2014.